Multidrug Regimen Seen Challenging Recently Approved Drugs from Gilead Sciences U.S. regulators on Friday...
Read More
– In Phase 3 clinical trials, VIEKIRA PAK cured 95-100 percent of hepatitis C...
It’s becoming health threat at young age When David Martinez was diagnosed with advanced...
Two studies suggest drugs could yield high cure rates. A new study suggests that...
Can outcomes be sustained with shorter regimens? A new study suggests that some subgroups...
S. Texas Latinos have nation’s highest rate Experts are sounding the alarm on liver...
We got an overview on this important session at The Liver Meeting® 2014 which...
A San Antonio doctor has published a cure for hepatitis C, one of the...
San Antonio researcher leads national study that included hard-to-treat patients SAN ANTONIO ― Researchers...
Miami, Florida — New data offers hope to liver transplant patients infected with the hepatitis C...